Viewing Study NCT00950768


Ignite Creation Date: 2025-12-24 @ 5:34 PM
Ignite Modification Date: 2026-02-24 @ 5:09 AM
Study NCT ID: NCT00950768
Status: COMPLETED
Last Update Posted: 2009-08-03
First Post: 2009-07-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Melphalan 200 mg/m2 Versus Melphalan 100 mg/m2 in Newly Diagnosed Myeloma Patients
Sponsor: Azienda Ospedaliera San Giovanni Battista
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
None Diagnosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Myeloma View
None Melphalan View
None Autologous transplantation View